These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 21653834)

  • 1. Yersinia pestis YopE contains a dominant CD8 T cell epitope that confers protection in a mouse model of pneumonic plague.
    Lin JS; Szaba FM; Kummer LW; Chromy BA; Smiley ST
    J Immunol; 2011 Jul; 187(2):897-904. PubMed ID: 21653834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A protective epitope in type III effector YopE is a major CD8 T cell antigen during primary infection with Yersinia pseudotuberculosis.
    Zhang Y; Mena P; Romanov G; Lin JS; Smiley ST; Bliska JB
    Infect Immun; 2012 Jan; 80(1):206-14. PubMed ID: 22064714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TNFα and IFNγ but not perforin are critical for CD8 T cell-mediated protection against pulmonary Yersinia pestis infection.
    Szaba FM; Kummer LW; Duso DK; Koroleva EP; Tumanov AV; Cooper AM; Bliska JB; Smiley ST; Lin JS
    PLoS Pathog; 2014 May; 10(5):e1004142. PubMed ID: 24854422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccination with live Yersinia pestis primes CD4 and CD8 T cells that synergistically protect against lethal pulmonary Y. pestis infection.
    Philipovskiy AV; Smiley ST
    Infect Immun; 2007 Feb; 75(2):878-85. PubMed ID: 17118978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel CTL epitopes identified through a Y. pestis proteome-wide analysis in the search for vaccine candidates against plague.
    Zvi A; Rotem S; Zauberman A; Elia U; Aftalion M; Bar-Haim E; Mamroud E; Cohen O
    Vaccine; 2017 Oct; 35(44):5995-6006. PubMed ID: 28606812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. D27-pLpxL, an avirulent strain of Yersinia pestis, primes T cells that protect against pneumonic plague.
    Szaba FM; Kummer LW; Wilhelm LB; Lin JS; Parent MA; Montminy-Paquette SW; Lien E; Johnson LL; Smiley ST
    Infect Immun; 2009 Oct; 77(10):4295-304. PubMed ID: 19620344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intranasal delivery of a protein subunit vaccine using a Tobacco Mosaic Virus platform protects against pneumonic plague.
    Arnaboldi PM; Sambir M; D'Arco C; Peters LA; Seegers JF; Mayer L; McCormick AA; Dattwyler RJ
    Vaccine; 2016 Nov; 34(47):5768-5776. PubMed ID: 27745954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complete Protection against Pneumonic and Bubonic Plague after a Single Oral Vaccination.
    Derbise A; Hanada Y; Khalifé M; Carniel E; Demeure CE
    PLoS Negl Trop Dis; 2015; 9(10):e0004162. PubMed ID: 26473734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell-mediated protection against pulmonary Yersinia pestis infection.
    Parent MA; Berggren KN; Kummer LW; Wilhelm LB; Szaba FM; Mullarky IK; Smiley ST
    Infect Immun; 2005 Nov; 73(11):7304-10. PubMed ID: 16239527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of CD8+ T cell-mediated immune responses in LcrV DNA vaccine induced protection against lethal Yersinia pestis challenge.
    Wang S; Goguen JD; Li F; Lu S
    Vaccine; 2011 Sep; 29(39):6802-9. PubMed ID: 21199697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-17 contributes to cell-mediated defense against pulmonary Yersinia pestis infection.
    Lin JS; Kummer LW; Szaba FM; Smiley ST
    J Immunol; 2011 Feb; 186(3):1675-84. PubMed ID: 21172869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rational considerations about development of live attenuated Yersinia pestis vaccines.
    Sun W; Curtiss R
    Curr Pharm Biotechnol; 2013; 14(10):878-86. PubMed ID: 24372254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Robust Th1 cellular and humoral responses generated by the Yersinia pestis rF1-V subunit vaccine formulated to contain an agonist of the CD137 pathway do not translate into increased protection against pneumonic plague.
    Bowen W; Batra L; Pulsifer AR; Yolcu ES; Lawrenz MB; Shirwan H
    Vaccine; 2019 Sep; 37(38):5708-5716. PubMed ID: 31416643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Developing subunit immunogens using B and T cell epitopes and their constructs derived from the F1 antigen of Yersinia pestis using novel delivery vehicles.
    Sabhnani L; Manocha M; Sridevi K; Shashikiran D; Rayanade R; Rao DN
    FEMS Immunol Med Microbiol; 2003 Oct; 38(3):215-29. PubMed ID: 14522457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Yersinia pestis V protein epitopes recognized by CD4 T cells.
    Parent MA; Berggren KN; Mullarky IK; Szaba FM; Kummer LW; Adamovicz JJ; Smiley ST
    Infect Immun; 2005 Apr; 73(4):2197-204. PubMed ID: 15784563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intranasal administration of an inactivated Yersinia pestis vaccine with interleukin-12 generates protective immunity against pneumonic plague.
    Kumar D; Kirimanjeswara G; Metzger DW
    Clin Vaccine Immunol; 2011 Nov; 18(11):1925-35. PubMed ID: 21880856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An encapsulated Yersinia pseudotuberculosis is a highly efficient vaccine against pneumonic plague.
    Derbise A; Cerdà Marín A; Ave P; Blisnick T; Huerre M; Carniel E; Demeure CE
    PLoS Negl Trop Dis; 2012; 6(2):e1528. PubMed ID: 22348169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-throughput identification of new protective antigens from a Yersinia pestis live vaccine by enzyme-linked immunospot assay.
    Li B; Zhou L; Guo J; Wang X; Ni B; Ke Y; Zhu Z; Guo Z; Yang R
    Infect Immun; 2009 Oct; 77(10):4356-61. PubMed ID: 19651863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protection against pneumonic plague following oral immunization with a non-replicating vaccine.
    Jones A; Bosio C; Duffy A; Goodyear A; Schriefer M; Dow S
    Vaccine; 2010 Aug; 28(36):5924-9. PubMed ID: 20600517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of Neutrophil Primary Granule Release during Yersinia pestis Pulmonary Infection.
    Eichelberger KR; Jones GS; Goldman WE
    mBio; 2019 Dec; 10(6):. PubMed ID: 31822588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.